{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Stem Cell Treatment for Diabetic Foot Ulcers: A Meta-analysis of Randomized Clinical Trials
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Purpose of Activity
To provide information on the efficacy of stem cells in the treatment of diabetic foot ulcers.Learning Objectives
After completing this continuing education activity you will be able to:
- Explain outcomes from the use of stem cell treatment for diabetic foot ulcers.
- Identify features in the methodology of randomized controlled trials examining the efficacy of stem cells in the treatment of diabetic foot ulcers.
Learning Outcomes
Seventy-five percent of participants will demonstrate knowledge of the efficacy of stem cells in the treatment of diabetic foot ulcers by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
All authors, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Price:
$24.95
Credits:
- ANCC 2.5 CH
- DC - BON 2.5 CH
- FL - BON 2.5 CH
- GA - BON 2.5 CH
- NM - BON 2.5 CH
- SC - BON 2.5 CH
- WV - BOERN 2.5 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: ASWC0523
Published: May 2023
Expires: 3/6/2026
Required Passing Score: 8/10 (80%)